Clinical Trial Update: Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sirolimus therapy for idiopathic membranous nephropathy and lupus membranous nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Membranous Nephropathy
• Membranous Glomerulonephritis

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Membranous Glomerulonephritis, Lupus Membranous Nepropathy | Phase 2 | Status: COMPLETED